comparemela.com

Latest Breaking News On - Exon skipping therapy - Page 1 : comparemela.com

Top 5 Most-Read DMD Articles of 2023

Exon-Skipping Therapy for DMD Linked to High Care Costs, Health Care Resource Utilization

This comprehensive comparative analysis examined the economic and health care resource utilization implications of initiating glucocorticoid and exon-skipping therapy for Duchenne muscular dystrophy (DMD).

REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.